LINC01506: LINC01506 is a long non-coding RNA (lncRNA) that has been studied in various contexts. In a study comparing tumor and normal tissues, LINC01506 did not show significant differences in expression [PMC10042692]. Another study analyzing RNA-seq data from SARS-CoV-2 positive and control samples identified LINC01506 as a down-regulated DElncRNA [PMC10036311]. In the context of glioblastoma multiforme (GBM), LINC01506 was identified as one of the six lncRNAs associated with immunophenotypes [PMC9977673]. Additionally, in a Sankey diagram analysis, LINC01506 was classified as a risk factor [PMC10054813]. Functionally, LINC01506 has been associated with the regulation of immune system and responses [PMC6652661]. In another study on GBM immunophenotypes, LINC01506 was one of the six im-lncRNAs consistently identified across different cohorts [PMC7874158]. Overall, these studies highlight the involvement of LINC01506 in various biological processes and its potential role as a biomarker or therapeutic target. However, further research is needed to fully understand its functional significance and clinical implications. References: - [PMC10042692] - [PMC10036311] - [PMC9977673] - [PMC10054813] - [PMC6652661] - [PMC7874158]